KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Other Non-Current Liabilities (2016 - 2025)

Exact Sciences (EXAS) has disclosed Other Non-Current Liabilities for 11 consecutive years, with $329.3 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 4.38% to $329.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $329.3 million through Dec 2025, up 4.38% year-over-year, with the annual reading at $329.3 million for FY2025, 4.38% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $329.3 million at Exact Sciences, up from $324.8 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $439.2 million in Q2 2021, with the low at $315.5 million in Q4 2024.
  • Average Other Non-Current Liabilities over 5 years is $355.8 million, with a median of $338.9 million recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities skyrocketed 776.57% in 2021, then decreased 18.69% in 2022.
  • Over 5 years, Other Non-Current Liabilities stood at $417.8 million in 2021, then fell by 15.64% to $352.5 million in 2022, then decreased by 4.67% to $336.0 million in 2023, then dropped by 6.1% to $315.5 million in 2024, then grew by 4.38% to $329.3 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $329.3 million, $324.8 million, and $315.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.